Literature DB >> 16622096

The future of glaucoma clinics.

A M S Morley1, I Murdoch.   

Abstract

The number of patients seen with glaucoma related pathologies is predicted to increase significantly over the next few years as a result of an ageing population, increased optometric screening, and raised public awareness. In addition, the recent glaucoma literature proposes more aggressive management of ocular hypertension, open angle glaucoma, and narrow angle pathologies. This will overburden many glaucoma services and demands a reappraisal of current management strategies. Using a database of patients compiled from their tertiary referral glaucoma service as an example, the authors discuss the current controversies relating to each glaucoma subtype, encompassing issues relating to disease prognosis, efficacy of treatment, and resource management. They also suggest a range of strategies aimed at streamlining glaucoma clinics. Examples include shared care schemes, multidisciplinary teams, clinic guidelines/protocols, and alteration of clinic review times. The predicted effect of such schemes on clinic workloads is discussed, together with any existing validation.

Entities:  

Mesh:

Year:  2006        PMID: 16622096      PMCID: PMC1857065          DOI: 10.1136/bjo.2005.085522

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  55 in total

1.  Comparison of optic nerve imaging methods to distinguish normal eyes from those with glaucoma.

Authors:  Michael J Greaney; Douglas C Hoffman; David F Garway-Heath; Mamdouh Nakla; Anne L Coleman; Joseph Caprioli
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-01       Impact factor: 4.799

2.  The effects of new topical treatments on management of glaucoma in Scotland: an examination of ophthalmological health care.

Authors:  D N Bateman; R Clark; A Azuara-Blanco; M Bain; J Forrest
Journal:  Br J Ophthalmol       Date:  2002-05       Impact factor: 4.638

3.  Do locally agreed guidelines for optometrists concerning the referral of glaucoma suspects influence referral practice?

Authors:  S A Vernon; G Ghosh
Journal:  Eye (Lond)       Date:  2001-08       Impact factor: 3.775

4.  Translating the OHTS results into clinical practice.

Authors:  George A Cioffi; Jeffrey M Liebmann
Journal:  J Glaucoma       Date:  2002-10       Impact factor: 2.503

5.  Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining vision.

Authors:  Jessica E Oliver; Matthew G Hattenhauer; David Herman; David O Hodge; Robert Kennedy; Michael Fang-Yen; Douglas H Johnson
Journal:  Am J Ophthalmol       Date:  2002-06       Impact factor: 5.258

6.  The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.

Authors:  Mae O Gordon; Julia A Beiser; James D Brandt; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J Philip Miller; Richard K Parrish; M Roy Wilson; Michael A Kass
Journal:  Arch Ophthalmol       Date:  2002-06

7.  The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

Authors:  Michael A Kass; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J Philip Miller; Richard K Parrish; M Roy Wilson; Mae O Gordon
Journal:  Arch Ophthalmol       Date:  2002-06

8.  Community refinement of glaucoma referrals.

Authors:  D B Henson; A F Spencer; R Harper; E J Cadman
Journal:  Eye (Lond)       Date:  2003-01       Impact factor: 3.775

9.  Progression of visual field loss in untreated glaucoma patients and glaucoma suspects in St. Lucia, West Indies.

Authors:  M Roy Wilson; Omofolasade Kosoko; Claude L Cowan; Pamela A Sample; Chris A Johnson; Gleb Haynatzki; Cheryl Enger; David Crandall
Journal:  Am J Ophthalmol       Date:  2002-09       Impact factor: 5.258

10.  Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.

Authors:  M Cristina Leske; Anders Heijl; Mohamed Hussein; Bo Bengtsson; Leslie Hyman; Eugene Komaroff
Journal:  Arch Ophthalmol       Date:  2003-01
View more
  10 in total

1.  Determinants of medication adherence to topical glaucoma therapy.

Authors:  Laura E Dreer; Christopher Girkin; Steven L Mansberger
Journal:  J Glaucoma       Date:  2012 Apr-May       Impact factor: 2.503

2.  The Portsmouth-based glaucoma refinement scheme: a role for virtual clinics in the future?

Authors:  S Trikha; C Macgregor; M Jeffery; J Kirwan
Journal:  Eye (Lond)       Date:  2012-07-06       Impact factor: 3.775

3.  The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial.

Authors:  Augusto Azuara-Blanco; Jennifer M Burr; Claire Cochran; Craig Ramsay; Luke Vale; Paul Foster; David Friedman; Zahidul Quayyum; Jimmy Lai; Winnie Nolan; Tin Aung; Paul Chew; Gladys McPherson; Alison McDonald; John Norrie
Journal:  Trials       Date:  2011-05-23       Impact factor: 2.279

4.  Changes in trend of newly prescribed anti-glaucoma medications in recent nine years in a Japanese local community.

Authors:  Kenji Kashiwagi
Journal:  Open Ophthalmol J       Date:  2010-04-28

5.  Diurnal variation of intraocular pressure in suspected glaucoma patients and their outcome.

Authors:  I Tajunisah; S C Reddy; J Fathilah
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-09-28       Impact factor: 3.117

6.  A Common Glaucoma-risk Variant of SIX6 Alters Retinal Nerve Fiber Layer and Optic Disc Measures in a European Population: The EPIC-Norfolk Eye Study.

Authors:  Anthony P Khawaja; Michelle P Y Chan; Jennifer L Y Yip; David C Broadway; David F Garway-Heath; Ananth C Viswanathan; Robert Luben; Shabina Hayat; Michael A Hauser; Nicholas J Wareham; Kay-Tee Khaw; Brad Fortune; R Rand Allingham; Paul J Foster
Journal:  J Glaucoma       Date:  2018-09       Impact factor: 2.503

7.  Selective laser trabeculoplasty (SLT) performed by optometrists for patients with glaucoma and ocular hypertension: a scoping review protocol.

Authors:  Lee Jones; Evgenia Konstantakopoulou; Gus Gazzard
Journal:  BMJ Open Ophthalmol       Date:  2020-05-25

Review 8.  Advanced glaucoma at diagnosis: current perspectives.

Authors:  Alan Kastner; Anthony J King
Journal:  Eye (Lond)       Date:  2019-11-18       Impact factor: 3.775

9.  Why a successful task substitution in glaucoma care could not be transferred from a hospital setting to a primary care setting: a qualitative study.

Authors:  Kim M Holtzer-Goor; Thomas Plochg; Hans G Lemij; Esther van Sprundel; Marc A Koopmanschap; Niek S Klazinga
Journal:  Implement Sci       Date:  2013-01-25       Impact factor: 7.327

Review 10.  Investigation of medication adherence and reasons for poor adherence in patients on long-term glaucoma treatment regimes.

Authors:  Julie F McClelland; Lynne Bodle; Julie-Anne Little
Journal:  Patient Prefer Adherence       Date:  2019-08-12       Impact factor: 2.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.